B Scheller

Summary

Affiliation: Saarland University
Country: Germany

Publications

  1. ncbi Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting
    Bruno Scheller
    Internal Medicine III Cardiology, University of Saarland, Homburg Saar, Germany
    Invest Radiol 37:29-34. 2002
  2. ncbi Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis
    Bruno Scheller
    Department of Internal Medicine III Cardiology Angiology, University of Saarland, Homburg Saar, Germany
    Circulation 110:810-4. 2004
  3. ncbi Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting
    B Scheller
    University of Saarland Internal Medicine III, 66421 Homburg Saar, Germany
    Z Kardiol 92:1025-8. 2003
  4. ncbi Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
    Bruno Scheller
    Internal Medicine III Cardiology Angiology, University of Saarland, Homburg Saar, Germany
    J Am Coll Cardiol 42:1415-20. 2003
  5. ncbi Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction
    Bruno Scheller
    Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 42:634-41. 2003
  6. ncbi Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model
    Bruno Scheller
    Internal Medicine III, University of Saarland, D 66421 Homburg Saar, Germany
    Eur Heart J 24:1462-7. 2003
  7. ncbi [Impact of GP IIb/IIIa antagonists in interventional cardiology]
    B Scheller
    Innere Medizin III, Kardiologie/Angiologie, , Homburg/Saar
    Dtsch Med Wochenschr 128:281-7. 2003
  8. ncbi Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model
    B Scheller
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Z Kardiol 94:445-52. 2005
  9. ncbi Complete arterial revascularization using T-graft technique in diabetics with coronary three-vessel disease
    T Markwirth
    Medizinische Klinik III Kardiologie Angiologie Universitätskliniken des Saarlandes, Homburg Saar, Germany
    Thorac Cardiovasc Surg 48:269-73. 2000
  10. ncbi Effect of X-ray contrast media on blood flow properties after coronary angiography
    B Scheller
    Internal Medicine III Cardiology Angiology, Saarland University Clinic, Homburg Saar, Germany
    Thromb Res 96:253-60. 1999

Detail Information

Publications26

  1. ncbi Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting
    Bruno Scheller
    Internal Medicine III Cardiology, University of Saarland, Homburg Saar, Germany
    Invest Radiol 37:29-34. 2002
    ..The aim of this study was to comparatively evaluate the cardiovascular tolerability of iopromide, ioxaglate, and iosmin, and of a novel taxane protaxel, dissolved in iopromide, as a carrier, by coronary angiography and stenting...
  2. ncbi Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis
    Bruno Scheller
    Department of Internal Medicine III Cardiology Angiology, University of Saarland, Homburg Saar, Germany
    Circulation 110:810-4. 2004
    ..The aim of the present study was to evaluate a novel method of local drug delivery based on angioplasty balloons...
  3. ncbi Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting
    B Scheller
    University of Saarland Internal Medicine III, 66421 Homburg Saar, Germany
    Z Kardiol 92:1025-8. 2003
    ..The aim of the present study was to test the efficacy of an atorvastatin stent coating for restenosis inhibition in the porcine coronary stent model...
  4. ncbi Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
    Bruno Scheller
    Internal Medicine III Cardiology Angiology, University of Saarland, Homburg Saar, Germany
    J Am Coll Cardiol 42:1415-20. 2003
    ..The present study was designed to test the efficacy of paclitaxel added to the contrast agent iopromide in the prevention of restenosis...
  5. ncbi Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction
    Bruno Scheller
    Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 42:634-41. 2003
    ..The Southwest German Interventional Study in Acute Myocardial Infarction (SIAM III) investigated potentially beneficial effects of immediate stenting after thrombolysis as opposed to a more conservative treatment regimen...
  6. ncbi Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model
    Bruno Scheller
    Internal Medicine III, University of Saarland, D 66421 Homburg Saar, Germany
    Eur Heart J 24:1462-7. 2003
    ..The aim of this study was to test a novel taxane-contrast agent formulation for this new approach in the setting of coronary stenting...
  7. ncbi [Impact of GP IIb/IIIa antagonists in interventional cardiology]
    B Scheller
    Innere Medizin III, Kardiologie/Angiologie, , Homburg/Saar
    Dtsch Med Wochenschr 128:281-7. 2003
  8. ncbi Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model
    B Scheller
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Z Kardiol 94:445-52. 2005
    ..The aim of our study was the preclinical evaluation of tacrolimus in a drug eluting nonerodable polymer stent system and its comparison with paclitaxel...
  9. ncbi Complete arterial revascularization using T-graft technique in diabetics with coronary three-vessel disease
    T Markwirth
    Medizinische Klinik III Kardiologie Angiologie Universitätskliniken des Saarlandes, Homburg Saar, Germany
    Thorac Cardiovasc Surg 48:269-73. 2000
    ..The objective of this prospective study was to compare functional und angiographic parameters of arterial T-grafts in diabetics and nondiabetics...
  10. ncbi Effect of X-ray contrast media on blood flow properties after coronary angiography
    B Scheller
    Internal Medicine III Cardiology Angiology, Saarland University Clinic, Homburg Saar, Germany
    Thromb Res 96:253-60. 1999
    ..The most pronounced decrease in Hct was found using the ionic dimer ioxaglate. There were no significant differences between the contrast media with respect to their effects on PV, EA, and PRI...
  11. ncbi Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon
    B Cremers
    Clinic of Internal Medicine III, Saarland University Hospital, Homburg Saar, Germany
    Minerva Cardioangiol 58:583-8. 2010
    ..Randomized, controlled clinical trials are warranted to further evaluate this promising approach...
  12. ncbi Long-term follow-up of a randomized study of primary stenting versus angioplasty in acute myocardial infarction
    B Scheller
    Department of Cardiology, Division of Internal Medicine III, University of Saarland, Homburg/Saar, Germany
    Am J Med 110:1-6. 2001
    ..20). CONCLUSION: Primary stenting in acute myocardial infarction is significantly superior to angioplasty alone in both short-term and long-term follow-up...
  13. ncbi Do changes in blood flow in the subclavian artery affect flow volume in IMA grafts after complete arterial revascularization with the T-graft technique?
    B Hennen
    Medizinische Klinik III Kardiologie Angiologie, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Thorac Cardiovasc Surg 49:84-8. 2001
    ..The objective of this study was to determine whether changes in blood flow in the subclavian artery affect the flow in IMA grafts in patients who have undergone complete arterial revascularization with T-grafts...
  14. ncbi Intra-aortic counterpulsation during carotid stenting
    B Hennen
    Medizinische Klinik III Kardiologie Angiologie, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Catheter Cardiovasc Interv 53:546-8. 2001
    ..Controlled studies are necessary to demonstrate a potentially protective role of IABP in high-risk CAS patients...
  15. ncbi Acute and subacute stent occlusion; risk-reduction by ionic contrast media
    B Scheller
    Division of Internal Medicine III, University of Saarland, Homburg/Saar, Germany
    Eur Heart J 22:385-91. 2001
    ..9% vs 16.3%, P=0.001). CONCLUSIONS: Based upon these data, we recommend the use of Ioxaglate in coronary interventions when stent placement is anticipated...
  16. ncbi Opportunities and limitations of drug-coated balloons in interventional therapies
    B Scheller
    Klinik fur Innere Medizin III, Klinische und Experimentelle Interventionelle Kardiologie, Universitatsklinikum des Saarlandes, Homburg Saar, Deutschland
    Herz 36:232-9. 2011
    ....
  17. ncbi Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine
    Thomas Albrecht
    Department of Radiology and Nuclear Medicine, Campus Benjamin Franklin, Charite, Free University und Humboldt University Berlin, Berlin, Germany
    Invest Radiol 42:579-85. 2007
    ....
  18. ncbi Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
    Bruno Scheller
    Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    N Engl J Med 355:2113-24. 2006
    ..Treatment of coronary in-stent restenosis is hampered by a high incidence of recurrent in-stent restenosis. We assessed the efficacy and safety of a paclitaxel-coated balloon in this setting...
  19. ncbi Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries
    Ulrich Speck
    Department of Radiology, Charite Humboldt University Berlin, Schumannstr 20 21, D 10117 Berlin, Germany
    Radiology 240:411-8. 2006
    ..To compare the inhibition of neointimal proliferation by using non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries...
  20. ncbi Drug delivery by angiographic contrast media: inhibition of restenosis
    Ulrich Speck
    Dept. of Radiology, , Berlin, Germany
    Acad Radiol 12:S14-7. 2005
  21. ncbi Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function
    Sven Wassmann
    Medizinische Klinik und Poliklinik, Innere Medizin III, , D-66421 Homburg/Saar, Germany
    Circ Res 93:e98-103. 2003
    ..Statin treatment improves endothelium-dependent coronary vasomotion within 24 hours in the absence of significant cholesterol reduction. The full text of this article is available online at http://www.circresaha.org...
  22. ncbi Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media
    Ulrich Speck
    Department of Radiology, Charite, Humboldt University, Berlin, Germany
    Invest Radiol 39:182-6. 2004
    ..This study determined early local tissue concentrations after the administration of different paclitaxel doses and preparations...
  23. ncbi No difference among modern contrast media's effect on neointimal proliferation and restenosis after coronary stenting in pigs
    Wolfram Clauss
    Schering AG, Berlin, Germany
    Invest Radiol 38:743-9. 2003
    ..CONCLUSIONS: Under the experimental conditions iopromide, ioxaglate, and iosimenol had no or very similar direct or otherwise mediated effect on cell proliferation and restenosis...
  24. ncbi Paradigms and perspectives in contrast media research
    Ulrich Speck
    Department of Radiology, Charit, Humboldt University, Berlin, Germany
    Acad Radiol 9:S392-7. 2002
  25. ncbi Prevention of restenosis: is angioplasty the answer?
    Bruno Scheller
    Heart 93:539-41. 2007
    ..quot;The drug-coated balloon has the potential to improve the limited results of drug-eluting stents"..
  26. ncbi Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg
    Gunnar Tepe
    Radiologische Klinik, Diagnostische und Interventionelle Radiologie, Eberhard Karls Universitat, Tubingen, Germany
    N Engl J Med 358:689-99. 2008
    ..We investigated the use of paclitaxel-coated angioplasty balloons and paclitaxel dissolved in the angiographic contrast medium during angioplasty of the leg...